Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNo textual additions or deletions are documented for this record.SummaryDifference0.1%

- Check15 days agoChange DetectedA new site revision entry Revision: v3.5.4 was added to the history, replacing the prior v3.5.3. This reflects a general site update rather than a modification to study content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.5.3 has been added to the record history. The previous revision v3.5.2 has been removed from the history, reflecting an update to the metadata of the study record.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision history shows an addition of v3.4.3 and a deletion of v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.